Your browser version may not work well with NCBI's Web applications. More information here...
1: J Rheumatol. 2001 Apr;28(4):868-70.Click here to read Links

Treatment of Felty's syndrome with leflunomide.

Talip F, Walker N, Khan W, Zimmermann B.

Department of Rheumatology, Roger Williams Medical Center, Boston University School of Medicine, Massachusetts, USA.

Felty's syndrome (FS) is a rare manifestation of severe rheumatoid arthritis (RA). It is an immune mediated inflammatory process, usually treated with standard disease modifying antirheumatic drugs. We describe a case of severe FS that developed in a patient receiving methotrexate therapy for RA. Treatment with etanercept resulted in severe allergic cutaneous reactions. The patient subsequently responded to treatment with leflunomide. The response included dramatic improvement of leukopenia and neutropenia as well as excellent control of his arthritis. Leflunomide has recently been used effectively for the treatment of RA and may be useful for the management of patients with FS.

PMID: 11327265 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Methotrexate (Rheumatrex® , Trexall® )

    Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physica...

  • Leflunomide (Arava® )

    Leflunomide is used to treat rheumatoid arthritis. Leflunomide decreases the symptoms of rheumatoid arthritis and slows damage to joints caused by the disease.

  • Abatacept (Orencia, Humira, Amevive, ...)

    How do targeted immune modulators compare in treating rheumatoid arthritis?

  • Source: AHFS Consumer Medication Information